Wnts stimulate cell migration, although the mechanisms responsible for this effect are not fully understood. To investigate the pathways that mediate Wnt-dependent cell motility, we treated CHO cells with Wnt-3a-conditioned medium and monitored changes in cell shape and movement.
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INTRODUCTION
The Wnts comprise a large family of secreted glycoproteins that have multiple roles in the development of organisms ranging from worms and flies to mammals. Wnts regulate cell proliferation, differentiation, polarity, survival and migration, and affect the organization of the body plan, organogenesis and tissue patterning (1) (2) . Moreover, constitutive activation of Wnt signaling contributes to the etiology of several human cancers and also may participate in metastasis (3) (4) (5) (6) .
Several signaling pathways have been implicated in Wnt-dependent cell motility. The most widely studied Wnt signal transduction scheme is the canonical Wnt or β-catenin pathway [reviewed in (7) ]. In the absence of Wnt stimulation, soluble β-catenin levels are low as a result of ubiquitin-dependent proteolysis. Wnt binding to a Frizzled (Fz) 1 7-pass transmembrane receptor and either low density lipoprotein receptor-related protein 5 or 6 (LRP5/6, Arrow in 4 various model systems. Although activation of all the key effectors in the Wnt/Ca 2+ /PKC pathway (24) has not been documented in cell motility models, there are numerous reports of Wnt-dependent, PKC activity contributing to cell migration (25) (26) (27) .
The present study was initiated to establish a simple model in which the mechanisms of Wnt-dependent cell motility could be examined. We used soluble biologically active Wnt-3a,
which had been previously shown to stimulate rearrangement of the actin cytoskeleton (28) , and
Chinese hamster ovary (CHO) cells, a line that had served in prior analysis of Wnt signaling (29) .
We documented Wnt-dependent changes in cell shape and enhancement of cell movement in wound healing (scratch) and transwell assays. Cell motility was not inhibited by disruption of the β-catenin pathway, but was partially blocked by a ROCK inhibitor. Surprisingly, motility was markedly decreased when Dvl-2 expression was specifically reduced by small interference RNA methodology. In cells expressing a normal level of Dvl-2, Wnt-3a treatment elicited changes in the distribution of Dvl-2 protein consistent with a role in cell movement. These findings provide useful insights into the mechanisms responsible for Wnt-dependent cell motility, and in particular indicate an important function for Dvl-2 in mediating CHO cell movement elicited by Wnt-3a.
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EXPERIMENTAL PROCEDURES
Reagents-A murine Wnt-3a cDNA, kindly provided by Dr. Shinji Takada, was transfected into L cells and a stable clonal line was selected that released β-catenin-stabilizing activity into serum-free CM. Wnt-3a CM and CM from non-transfected L cells were harvested from confluent monolayers that had been grown in serum-containing medium, but subsequently were incubated for 72 h in serum-free EMEM supplemented with non-essential amino acids, L-glutamine (2 mM), sodium pyruvate (1 mM), penicillin (100 units/ml) and streptomycin (100 µg/ml). Typically, CM was stored at -80 o C; once thawed, medium was kept refrigerated and retained activity for several weeks (activity was lost if material was subjected to another round of freeze-thawing). Recombinant secreted Frizzled-related protein-1 (sFRP-1) was purified as previously described (30) . Human Dickkopf-1 (Dkk-1) was obtained from R&D systems Cell Culture and Transfection-Early passage CHO-K1 cells were maintained in Ham's F12 medium supplemented with 10% fetal bovine serum, glutamine (2 mM), penicillin (100 units/ml) and streptomycin (100 µg/ml). and incubation for 1-2 h at 4 o C. The beads were pelleted and washed twice with cell lysis buffer prior to SDS-PAGE. Phosphatase treatment was performed as previously described (33) .
Rho A Activation Assay-RhoA activation was demonstrated with a GST-RBD pull-down assay, essentially as previously described (22) . Because the recombinant fusion protein was labile, aliquots of bacteria expressing the protein were snap-frozen on liquid nitrogen and stored at Statistical Analysis-The Wilcoxon rank-sum test was used to evaluate the significance of differences in cell spreading (area of cell/cover slip contact) among the treatment groups. The significance of differences in data obtained from transwell and luciferase reporter assays was determined with Student's two-tailed t-test. Differences were considered to be significant when P with L CM or Wnt-3a CM containing sFRP-1, indicating that cell migration was Wnt-dependent.
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RESULTS
Wnt-3a Stimulates Morphological Changes and CHO Cell
We observed chemotactic activity of Wnt-3a CM in a standard transwell assay ( Figure 2B ).
In this scheme, cells were placed in the upper chamber with serum-free Eagle's Minimal Essential 11 Medium (EMEM) and separated from the lower chamber containing test medium by a filter with an 8 µm pore size. After 6 h, very few cells had migrated to the bottom of the filter when EMEM was in the lower chamber. A larger fraction of cells passed through the filter when L CM was in the lower chamber, and the number more than doubled to 20-30% of the total cell population following exposure to Wnt-3a CM ( Figure 2B ). When CM was added to the top chamber rather than the bottom, there was little difference in response to Wnt-3a or L CM, demonstrating that the previously described results were due to enhanced directional movement. Cells that migrated through the filter in response to Wnt-3a CM had an elongated shape with prominent extensions, whereas cells exposed to L CM retained a more rounded shape and a smoother surface with few extensions ( Figure 2C ). This implied that L CM stimulated an amoeboid-type movement, while
Wnt treatment induced sustained changes in cell shape that augmented migration. Preincubation of Wnt-3a CM with sFRP-1 reduced activity in the transwell assay by > 80%. sFRP-1 also had an inhibitory effect on L CM in this assay ( Figure 2B and 2C).
Canonical Wnt/β-catenin Pathway is Activated by Wnt-3a CM, but not Required for
Motility or Associated Changes in Cell Shape-As previously reported for L cells (28) , Wnt-3a CM stimulated a large increase in β-catenin protein in CHO cells ( Figure 3A ). This effect was seen in whole cell lysates after 1 h, maximal at 3 h and still evident at 24 h. In contrast, only weak stimulation was observed with L CM. The accumulation of β-catenin in cells treated with Wnt-3a CM was markedly reduced by 10 µg/ml of sFRP-1 or 1 µg/ml of Dkk-1 ( Figure 3B ).
To determine whether β-catenin signaling was required for cell motility, transwell assays were performed with inhibitors of this pathway. Dkk-1 is a specific inhibitor of the canonical Wnt pathway, as it binds to LRP-5 or -6 but not to Wnt proteins themselves, and therefore does not disrupt Wnt/Fz signaling through non-canonical pathways (35) (36) (37) . As shown in Figure 3C , Dkk-1 did not inhibit Wnt-3a-associated chemotaxis. Surprisingly, Dkk-1 increased motility when cells were exposed either to L or Wnt-3a CM. Consistent with these results, Dkk-1 did not block the motility-associated morphological changes observed in cells treated with Wnt-3a CM 12 ( Figures 1 and 3D ).
DN-TCF is another specific antagonist of the canonical Wnt pathway (31) . We verified that this construct inhibited TCF/β-catenin TOPFLASH reporter activity in CHO cells treated with Wnt-3a CM ( Figure 3E ). However, expression of DN-TCF did not reduce cell migration in the transwell assay ( Figure 3F ), nor did it inhibit Wnt-3a-associated changes in cell shape (see supplementary information, Figure 3G ). Taken together, the results with Dkk-1 and DN-TCF demonstrated that the canonical Wnt pathway was not required for chemotaxis or the related changes in cell morphology. Dvl-3 that typically was associated with the formation of a doublet band in response to Wnt-3a but not L CM ( Figure 5A ). The mobility shifts of both Dvl-2 and Dvl-3 were inhibited by preincubation with sFRP-1 ( Figure 5B ) and reversed by treatment of immunoprecipitated Dvl protein with alkaline phosphatase ( Figure 5C ). These findings indicated that the changes in Dvl isoforms were attributable to Wnt-dependent phosphorylation, consistent with observations previously made in other cells (39, 40) . Interestingly, these mobility shifts have been reported to correlate with non-canonical Wnt signaling (41). antibodies were not effective for immunocytochemistry, we focused our attention on Dvl-2. Prior to addition of Wnt-3a CM, Dvl-2 was seen diffusely throughout the cytoplasm ( Figure 6A ). By 1 h after Wnt-3a treatment, the distribution of Dvl-2 protein had changed, with a portion localized to the plasma membrane and associated with cell extensions, while a substantial amount was adjacent to the nucleus. When Dvl-2 images were merged with phalloidin staining, there was a clear association of Dvl-2 with stress fibers. Similar findings were seen after 3 and 6 h, with Dvl-2 exhibiting both a nuclear and perinuclear distribution at the later time points. By comparison, there was some redistribution of Dvl-2 to the plasma membrane in response to the L CM, and a small shift of Dvl-2 from the periphery to a more central location ( Figure 6B ), but these changes were much less dramatic than the ones seen with Wnt-3a CM.
RhoA is Activated by Wnt-3a CM and Contributes to CHO Cell Motility-
Wnt-3a CM Elicits a Redistribution of Dvl-2 in CHO cells-
Dvl-2 Knock Down by RNAi Revealed an Important Role for Dvl-2 in CHO Cell Motility-
We used RNAi technology to investigate the involvement of individual Dvl isoforms in CHO cell motility. While attempts to knock down Dvl-1 and Dvl-3 efficiently and specifically were unsuccessful, the method was effective in specifically inhibiting the expression of Dvl-2. Figure 7D ).
Taken together, these results demonstrated that Dvl-2 had a major role in mediating CHO cell chemotactic activity and related morphological changes elicited by Wnt-3a CM.
DISCUSSION
In the present study, we used Wnt-3a CM to investigate the effects of Wnt protein on CHO cell shape and motility, and to determine the molecular pathways responsible for these effects. Cell spreading was evident within 1 h of exposure to Wnt-3a CM, followed by membrane protrusions and reorganization of stress fibers. Motility was demonstrated in a scratch assay and chemotaxis in a transwell assay. All of these responses were inhibited by recombinant sFRP-1, reinforcing the idea that they were specifically due to Wnt activity. While the methods and Wnt-dependent increase in cell spreading and a redistribution of Dvl protein to the ends of actin fibers as well as to the nucleus and perinuclear region. Our study extended these findings by using Wnt-3a CM rather than cocultures with Wnt-1-expressing cells, as this enabled us to monitor the time course of Dvl redistribution. We also used an antiserum that was specific for Dvl-2, rather than one that cross-reacted with both Dvl-1 and Dvl-2. The interaction of Dvl-2 with the actin cytoskeleton has been attributed to an actin binding motif within its DIX domain (29) . We surmise that the Wnt-dependent association of Dvl-2 with actin, particularly at sites of cellular extension, is indicative of its role in cell movement.
RhoA activation is one of the molecular mechanisms implicated in cell motility, as it was not a clear-cut difference in the responses to the two CM (unpublished data). We presume that extraneous factors are present in the L and perhaps also Wnt-3a CM that account for this activity, and likely contribute to the motility elicited by the CM in the transwell assay. PKC activation is another recently described mechanism of Wnt-dependent cell motility, associated with the activity of Wnt-5a on melanoma cells (26), DWnt-4 on Drosophila ovarian epithelial cells (25) and convergent extension movements in Xenopus (27) . These processes are thought to involve Dvl (25, 27) . Thus far, we have not obtained evidence of Wnt-dependent PKC activation in our CHO cell model system. In summary, there is credible evidence that RhoA activation occurs in CHO cells following treatment with Wnt-3a CM and contributes to their motility. Other pathways, 18 either downstream or independent of Dvl-2, may also be involved, though further investigation is required to elucidate these mechanisms.
One signaling mechanism that does not appear to participate in the morphological and motility changes observed in CHO cells is the canonical Wnt/β-catenin pathway. Wnt-3a CM stimulated a strong increase in β-catenin protein levels in whole cell lysates ( Figure 3A ), similar to previous findings with L cells (28) . However, inhibition of this increase by concomitant incubation with recombinant Dkk-1 ( Figure 3B ) did not disrupt Wnt-dependent cell shape changes or chemotaxis in the transwell assay ( Figures 3C and 3D) . Moreover, inhibition of the canonical pathway with a DN-TCF also failed to block these responses to Wnt-3a CM ( Figure 3F ). This is in contrast to reports showing that the β-catenin pathway was involved in the motility of bladder carcinoma and osteosarcoma cells in a transwell assay (8, 9) , but is consistent with many other studies that have demonstrated the importance of non-canonical Wnt pathways in motility, . When this material was tested in cell shape and transwell assays, we obtained results qualitatively similar to the ones described here for Wnt-3a CM, although the effects were not as strong (unpublished data). This reinforced the view that the activities attributed to Wnt-3a were genuine, but also suggested that additional factors in the CM contributed to CHO cell motility. As mentioned in the previous paragraph, endogenous Wnts may be present in CM, although their levels presumably were low given the weak activity of L CM in β-catenin stabilization and RhoA activation assays ( Figures 3A and 4A ). Other factors in CM that we inferred were involved in JNK activation also could have enhanced motility in the transwell assay.
Thus, it is likely that the responses of CHO cells to Wnt-3a CM are attributable to a combination of agents, though Wnt-3a is clearly a significant one. This view is reinforced by the contrasting 20 effects of Wnt-3a and L CM on cell shape and motility, and the ability of recombinant sFRP-1 to minimize these differences. Transwell assays were performed as described in 
